Clinical Drug Experience Knowledgebase

Ataxia (Phase 2)

Brain Neoplasms (Phase 2)

Bronchiolitis (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Cataract (Phase 2)

Cerebellar Ataxia (Phase 2)

Connective Tissue Diseases (Phase 3)

Corneal Endothelial Cell Loss (Phase 2)

Coronavirus Infections (Phase 3)

Cryptogenic Organizing Pneumonia (Phase 2)

Dermatitis (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 3)

Fibrosis (Phase 2)

Friedreich Ataxia (Phase 2)

Glioma (Phase 1)

Glomerulonephritis, IGA (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 2)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Idiopathic Interstitial Pneumonias (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Inflammation (Phase 2)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 2)

Liver Diseases (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Interstitial (Phase 2)

Lung Neoplasms (Phase 1)

Melanoma (Phase 2)

Meningeal Carcinomatosis (Phase 1)

Meningitis (Phase 1)

Mitochondrial Myopathies (Phase 2)

Muscular Diseases (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Second Primary (Phase 2)

Nephritis, Hereditary (Phase 3)

Pancreatic Neoplasms (Phase 2)

Pneumonia (Phase 2)

Polycystic Kidney, Autosomal Dominant (Phase 3)

Polycystic Kidney Diseases (Phase 3)

Pulmonary Fibrosis (Phase 2)

Radiodermatitis (Phase 2)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Sarcoidosis (Phase 2)

Syndrome (Phase 3)